IVERIC bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IVERIC bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2022.
  • IVERIC bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $269M, a 30.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $269M +$62.7M +30.4% Dec 31, 2022 10-K 2023-03-01
Q4 2021 $206M +$34.8M +20.3% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $172M +$29.3M +20.6% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $142M +$19.7M +16.1% Dec 31, 2019 10-K 2021-03-04
Q4 2018 $123M -$25M -16.9% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $148M -$86M -36.8% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $234M +$61.6M +35.8% Dec 31, 2016 10-K 2018-03-05
Q4 2015 $172M +$35.8M +26.3% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $136M +$72.1M +113% Dec 31, 2014 10-K 2016-02-26
Q4 2013 $64M +$21.4M +50.1% Dec 31, 2013 10-K/A 2015-07-28
Q4 2012 $42.7M Dec 31, 2012 10-K 2014-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.